Cathie Wood
YARW

Cathie Wood’s Yarrow Bioscience YARW Stock Holding History

Cathie Wood’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20
Closed -$197K – 216
2020
Q1 		$197K Buy
+20
New +$314K ﹤0.01% 174

Other funds holding YARW

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cathie Wood's YARW Position: Q2 2020 in Review

Cathie Wood sold out of Yarrow Bioscience (YARW) in Q2 2020, closing a stake of 20 shares — an estimated $197K sold.

Cathie Wood first reported a position in YARW in Q1 2020 and held it in 1 quarter. The position peaked at $197K in Q1 2020. 98 funds tracked by Wall St. Rank hold YARW as of Q2 2020.

  • Cathie Wood reported no remaining Yarrow Bioscience position as of Q2 2020 after selling out during the quarter.
  • Cathie Wood sold 20 Yarrow Bioscience shares in Q2 2020, an estimated $197K.
  • Cathie Wood first reported a position in Yarrow Bioscience in Q1 2020 and held it in 1 quarter.
  • Cathie Wood's Yarrow Bioscience position peaked at $197K in Q1 2020.
  • 98 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2020.

Based on ARK Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.